| Authors: |
Haslett K; Manchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK., De Ruysscher D; Department of Radiation Oncology (MAASTRO Clinic), Maastricht University Medical Centre, School for Oncology and Developmental Biology (GROW), The Netherlands; KU Leuven, Radiation Oncology, Belgium., Dziadziuszko R; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich (USZ), Switzerland., Pechoux CL; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Institut d' Oncologie Thoracique, Villejuif, France., Nestle U; Klinik für Strahlentherapie und Radiologische Onkologie, Kliniken Maria Hilf, Mönchengladbach, Germany., Slotman B; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands., Faivre-Finn C; Manchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: corinne.finn@christie.nhs.uk. |
